Shares of Bristol-Myers Squibb Co. (ticker: BMY) fell more than 16 percent Friday after the company announced that its Opdivo drug failed a study that would have expanded its use to lung cancer patients. BMY stock dropped more than …
news that hit Bristol-Myers stock hard and buoyed Merck's shares. Leerink analyst Seamus Fernandez said Keytruda's results support Merck's assertion of a "sea change" in this area of cancer treatment. "The nearly inexplicable failure of …
Carl Icahn didn't amass a net worth of an estimated $16.6 billion by making dumb moves. So when Dow Jones reported that the billionaire bought a stake in Bristol-Myers Squibb (NYSE: BMY), it captured the attention of the investment …
Bristol-Myers Squibb's stock fell nearly 10 percent yesterday after the company released a disappointing earnings forecast. The news helped send the prices of other drug stocks tumbling. . The shares of the Bristol-Myers Squibb …
Bristol-Myers Squibb (NYSE: BMY) investors might have been just a bit worried on Wednesday. After all, the U.S. Food and Drug Administration (FDA) had just placed a partial clinical hold on three clinical trials for Opdivo in combination …
Key highlights in the pharma sector include a complete response letter (“CRL”) from the FDA for Johnson & Johnson’s JNJ investigational rheumatoid arthritis (“RA”) treatment and FDA approval for Merck’s MRK and Bristol-Myers Squibb’s …
01:11p TransUnion's PT raised by SunTrust Banks, Inc. to $64.00. buy rating. 12:43p AbbVie stock price target raised to $105 from $95 at SunTrust RH #news 12:43p Bristol-Myers stock price target raised to $75 from $55 at SunTrust RH …
Bristol-Myers Co. disclosed plans Thursday to acquire Squibb Corp. in a stock transaction currently valued at about $11.5 billion. If completed, the giant deal would continue the consolidation in the worldwide pharmaceutical industry. It also …
Bristol-Myers Squibb Co (NYSE:BMY) stock has had a tumultuous 12-month period. In January, it fell 20% but luckily for the bulls it recovered all of it within five weeks. Since then and after several +/-8% moves, BMY is up 12% in 52 weeks …